If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: BioPharma Dive
Valence: Recursion to acquire two Canadian drug discovery startups
The company agreed to buy Cyclica and Valence after winnowing down a list of more than 100 potential takeover targets, its CEO told BioPharma Dive.
Read full article »
Valence's Competitors
|
Valence's News
|
Valence's Financials
Follow
Followers on Owler
142
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Co-Founder & CEO
Daniel Cohen
CEO Approval Rating
86/100
Weigh In
Read more
See Valence company profile »
